Target intelligence / Profile preview

Mycobacterium tuberculosis ATP synthase F1 catalytic core (Mtb F1-ATPase)

Target
Mtb F1-ATPase
Molecular classification
Enzyme, ATP synthase, Hydrolase
01

Overview

The Mycobacterium tuberculosis ATP synthase F1 catalytic core is the hydrophilic, extrinsic component of the F1F0-ATP synthase complex, which is essential for the bacterium's energy production (Lu et al., 2014, Journal of Bacteriology). It consists of a hexameric alpha3beta3 ring that contains the catalytic sites for ATP synthesis and hydrolysis, surrounding a central gamma subunit stalk that couples the proton-motive force from the F0 sector to mechanical rotation (Wong et al., 2017, Frontiers in Pharmacology). This enzyme is a critical therapeutic target because M. tuberculosis relies heavily on oxidative phosphorylation for survival during both active growth and latent infection phases (Andries et al., 2005, Science). While the FDA-approved drug Bedaquiline primarily binds to the c-ring of the F0 sector, the F1 catalytic core is an active area of drug discovery for identifying inhibitors that can disrupt the enzyme's rotational mechanism or catalytic turnover (Preiss et al., 2015, Science Advances). Targeting the F1 sector offers a strategy to overcome resistance associated with F0 mutations and provides a pathway for developing narrow-spectrum antitubercular agents. However, a major challenge in targeting this core is ensuring selectivity to avoid inhibiting the highly conserved human mitochondrial ATP synthase, which could lead to significant host toxicity (Bai et al., 2021, Bioorganic & Medicinal Chemistry).

Other names
F1-ATPaseF1 sectoralpha3beta3gamma complexATP synthase subunit alphaATP synthase subunit beta
02

Mechanism of action

Inhibition of the catalytic activity of the alpha3beta3 hexamer, preventing the synthesis of ATP from ADP and inorganic phosphate, thereby depleting cellular energy levels and leading to bacterial death (Wong et al., 2017).

03

Biological functions

ATP synthesisATP hydrolysisEnergy metabolismIon transport
04

Disease associations

Infection
05

Safety considerations

Potential cross-reactivity with human mitochondrial ATP synthaseMitochondrial toxicityDevelopment of drug resistance through mutations in atpA or atpD genesQT prolongation (associated with diarylquinolines targeting the complex)
06

Interacting drugs

Bedaquiline

4 more in the full profile.

07

Biomarkers

Sputum culture conversionTime to positivity (TTP) in liquid cultureMycobacterial DNA load

Beyond the preview

Go deeper on Mycobacterium tuberculosis ATP synthase F1 catalytic core (Mtb F1-ATPase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis ATP synthase F1 catalytic core (Mtb F1-ATPase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call